Latest market price
1.00
-0.01-0.99%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | 1.48 | Insider Own | — | Shs Outstand | 361.72M | Perf Week | -1.96% |
| Market Cap | 361.72M | Forward P/E | 6.93 | EPS next Y | 0.14 | Insider Trans | — | Shs Float | 354.55M | Perf Month | -1.96% |
| Enterprise Value | 130.72M | PEG | 0.02 | EPS next Q | — | Short Float | 0.04% | Perf Quarter | -8.26% | ||
| Income | 77.00M | P/S | 0.50 | EPS this Y | — | Short Ratio | 0.30 | Perf Half Y | -38.27% | ||
| Sales | 723.00M | P/B | 0.46 | EPS next Y | 36.06% | ROA | 6.88% | Short Interest | 149.68K | Perf YTD | -47.37% |
| Book/sh | 2.16 | P/C | 1.19 | EPS next 5Y | 32.60% | ROE | 10.56% | 52W High | 2.03 -50.74% | Perf Year | -41.86% |
| Cash/sh | 0.84 | P/FCF | — | EPS past 3/5Y | 109.40% — | ROIC | 6.58% | 52W Low | 0.96 4.17% | Perf 3Y | -1.96% |
| Dividend Est. | 0.06 (6.00%) | EV/EBITDA | 2.38 | Sales past 3/5Y | 9.02% 4.19% | Gross Margin | 57.14% | Volatility | 2.13% 2.28% | Perf 5Y | -54.95% |
| Dividend TTM | 0.06 (6.00%) | EV/Sales | 0.18 | EPS Y/Y TTM | 778.04% | Oper. Margin | 7.67% | ATR (14) | 0.03 | Perf 10Y | — |
| Dividend Ex-Date | Oct 09, 2026 | Quick Ratio | 2.19 | Sales Y/Y TTM | 74.64% | Profit Margin | 10.73% | RSI (14) | 42.98 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 2.19 | EPS Q/Q | -8.07% | SMA20 | -1.57% | Beta | -0.17 | Target Price | 2.00 |
| Payout | 0.00% | Debt/Eq | 0.09 | Sales Q/Q | 83.62% | SMA50 | -1.71% | Rel Volume | 0.35 | Prev Close | 1.01 |
| Employees | 3,018 | LT Debt/Eq | 0.00 | Earnings | Dec 09 | SMA200 | -27.39% | Avg Volume | 514.59K | Price | 1.00 |
| IPO Date | May 07, 2021 | Option/Short | No / Yes | EPS/Sales Surpr. | — 0.35% | Net Debt/EBITDA | -4.20 | Volume | 181,652 | Change | -0.99% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-29-25 | Reiterated | Goldman Sachs | Buy | $2.00 |
| Sep-16-22 | Upgrade | Morgan Stanley | Equal Weight → Overweight | |
| Sep-13-22 | Downgrade | Morgan Stanley | Overweight → Equal Weight | |
| Mar-25-22 | Downgrade | Morgan Stanley | Overweight → Equal Weight |
Latest News· Times ET
Oct-23-26
Oct-15-26
Oct-15-2609:17AM
Oct-07-26
Oct-07-2607:11AM
Oct-01-26
Oct-01-2604:01AM
Sep-08-26
12:15PM
Waterdrop Inc. (WDH) Q2 2026 Earnings Call Transcriptseekingalpha.com
10:04AM
Waterdrop Q2 Earnings Call Highlightsmarketbeat.com
07:09AM
06:00AM
Aug-25-26
Aug-25-2606:00AM
Aug-08-26
Jul-03-26
Jul-03-2601:03AM
Company
Waterdrop Inc., through its subsidiaries, provides online insurance brokerage services to match and connect users with related insurance products underwritten by insurance companies in the People’s Republic of China. The company offers short-term and long-term health and life insurance products and services. It also operates a medical crowdfunding platform; and E-Find, a clinical trial patient recruitment platform for pharmaceutical companies to find matches for clinical trials. In addition, the company provides technical services to insurance brokerage or agency companies through customer relationship management system. Waterdrop Inc. was founded in 2016 and is headquartered in Beijing, the People’s Republic of China.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 723 | 539 | 385 | 372 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 309 | 263 | 183 | 224 | — | — | — | — | — | |
| Gross Profit | 414 | 276 | 203 | 148 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 322 | 194 | 148 | 106 | — | — | — | — | — | |
| Research and Development | 36 | 32 | 30 | 42 | — | — | — | — | — | |
| Other Operating Expense | 1 | -1 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 55 | 50 | 25 | -1 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 23 | 23 | 25 | 24 | — | — | — | — | — | |
| Net Income Before Taxes | 77 | 74 | 50 | 23 | — | — | — | — | — | |
| Income Taxes | -1 | -3 | 1 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 77 | 77 | 51 | 24 | — | — | — | — | — | |
| Net Income From Continuing Operations | 78 | 77 | 49 | 23 | — | — | — | — | — | |
| Net Income | 77 | 77 | 51 | 24 | — | — | — | — | — | |
| EPS (Recurring) | 1.59 | 2.14 | 0.14 | 0.06 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.59 | 2.14 | 0.14 | 0.06 | — | — | — | — | — | |
| EPS (Diluted) | 1.48 | 2.05 | 0.14 | 0.06 | — | — | — | — | — | |
| EBITDA | 55 | 52 | 26 | 1 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 0.68 | 0.93 | 8.49 | 17.13 | — | — | — | — | — | |
| Price To Sales Ratio | 0.05 | 0.13 | 1.13 | 1.08 | — | — | — | — | — | |
| Gross Margin | 57.26 | 51.21 | 52.73 | 39.78 | — | — | — | — | — | |
| Operating Margin | 7.61 | 9.28 | 6.49 | -0.27 | — | — | — | — | — | |
| Net Margin | 10.65 | 14.29 | 13.25 | 6.45 | — | — | — | — | — | |
| Shares Outstanding | 36 | 36 | 368 | 388 | — | — | — | — | — | |
| Market Capitalization | 36 | 68 | 434 | 404 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.